Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 173 | Sp2 | trade journal | 0.100 Q4 | 2 | 21 | 189 | 24 | 0 | 169 | 0.00 | 1.14 |  |
| 172 | Chinese Journal of Cancer Biotherapy | journal | 0.102 Q4 | 5 | 0 | 374 | 0 | 7 | 370 | 0.01 | 0.00 |  |
| 171 | 2009 IEEE 3rd International Conference on Nano/Molecular Medicine and Engineering, NANOMED 2009 | conference and proceedings | 0.104 | 6 | 0 | 70 | 0 | 7 | 69 | 0.00 | 0.00 |  |
| 170 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.107 Q4 | 40 | 0 | 6 | 0 | 1 | 6 | 0.00 | 0.00 | |
| 169 | Gene Therapy and Regulation | journal | 0.115 Q4 | 7 | 5 | 18 | 255 | 6 | 16 | 0.33 | 51.00 |  |
| 168 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 |  |
| 167 | Cellular Therapy and Transplantation | journal | 0.122 Q4 | 8 | 0 | 48 | 0 | 5 | 47 | 0.14 | 0.00 |  |
| 166 | European Pharmaceutical Review | trade journal | 0.124 Q4 | 9 | 49 | 102 | 968 | 20 | 94 | 0.22 | 19.76 | |
| 165 | Frontiers in Drug Design and Discovery | book series | 0.125 Q4 | 9 | 0 | 18 | 0 | 3 | 17 | 0.00 | 0.00 |  |
| 164 | 2010 IEEE International Conference on Nano/Molecular Medicine and Engineering, IEEE NANOMED 2010 | conference and proceedings | 0.130 | 5 | 0 | 53 | 0 | 15 | 50 | 0.28 | 0.00 | |
| 163 | Nucleus (India) | journal | 0.133 Q4 | 17 | 27 | 4 | 744 | 2 | 4 | 0.50 | 27.56 |  |
| 162 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.135 Q4 | 14 | 26 | 59 | 1151 | 9 | 55 | 0.15 | 44.27 | |
| 161 | Pteridines | journal | 0.137 Q4 | 19 | 9 | 34 | 362 | 11 | 33 | 0.41 | 40.22 | |
| 160 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.144 Q4 | 16 | 51 | 162 | 1655 | 55 | 162 | 0.36 | 32.45 | |
| 159 | EXCLI Journal | journal | 0.144 Q4 | 55 | 81 | 92 | 3106 | 176 | 81 | 2.27 | 38.35 | |
| 158 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
| 157 | Open Bioactive Compounds Journal | journal | 0.170 Q4 | 6 | 0 | 6 | 0 | 9 | 6 | 0.33 | 0.00 |  |
| 156 | Turkish Journal of Pharmaceutical Sciences | journal | 0.179 Q4 | 22 | 33 | 74 | 999 | 32 | 74 | 0.37 | 30.27 |  |
| 155 | Gene Therapy and Molecular Biology | journal | 0.201 Q4 | 18 | 12 | 30 | 427 | 23 | 30 | 0.00 | 35.58 |  |
| 154 | Open Pharmacology Journal | journal | 0.201 Q4 | 6 | 5 | 10 | 400 | 11 | 10 | 1.80 | 80.00 | |
| 153 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q4 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | |
| 152 | Current Enzyme Inhibition | journal | 0.221 Q4 | 19 | 12 | 68 | 1077 | 49 | 65 | 0.65 | 89.75 | |
| 151 | Current Cancer Therapy Reviews | journal | 0.226 Q4 | 17 | 39 | 94 | 2649 | 57 | 93 | 0.56 | 67.92 | |
| 150 | Drug Discovery Today: Disease Models | journal | 0.228 Q4 | 33 | 33 | 65 | 1830 | 44 | 56 | 0.67 | 55.45 | |
| 149 | Frontiers in Medicinal Chemistry | book series | 0.231 Q4 | 7 | 17 | 44 | 2779 | 16 | 42 | 0.00 | 163.47 | |
| 148 | Biomolecules and Therapeutics | journal | 0.239 Q4 | 56 | 80 | 192 | 3528 | 146 | 192 | 0.83 | 44.10 |  |
| 147 | Topics in Medicinal Chemistry | book series | 0.243 Q4 | 15 | 9 | 33 | 1105 | 13 | 25 | 0.26 | 122.78 | |
| 146 | Yaoxue Xuebao | journal | 0.250 Q4 | 36 | 266 | 751 | 6333 | 522 | 750 | 0.74 | 23.81 | |
| 145 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.270 Q4 | 53 | 63 | 297 | 1923 | 249 | 296 | 0.84 | 30.52 | |
| 144 | Expert Opinion on Medical Diagnostics | journal | 0.274 Q4 | 28 | 53 | 149 | 4043 | 116 | 146 | 1.00 | 76.28 | |
| 143 | Letters in Drug Design and Discovery | journal | 0.284 Q4 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | |
| 142 | Virologica Sinica | journal | 0.293 Q4 | 47 | 48 | 158 | 1264 | 115 | 156 | 0.85 | 26.33 | |
| 141 | Personalized Medicine | journal | 0.339 Q4 | 36 | 100 | 240 | 2976 | 245 | 188 | 1.13 | 29.76 | |
| 140 | Probiotics and Antimicrobial Proteins | journal | 0.343 Q4 | 52 | 32 | 61 | 1450 | 69 | 60 | 1.17 | 45.31 | |
| 139 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q4 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | |
| 138 | Genetic Vaccines and Therapy | journal | 0.382 Q4 | 30 | 9 | 35 | 393 | 59 | 35 | 1.57 | 43.67 | |
| 137 | Journal of Biological Sciences (discontinued) | journal | 0.385 Q4 | 38 | 63 | 313 | 2089 | 360 | 313 | 1.31 | 33.16 |  |
| 136 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q4 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | |
| 135 | Current Pharmaceutical Analysis | journal | 0.425 Q4 | 27 | 48 | 96 | 1591 | 147 | 95 | 1.50 | 33.15 | |
| 134 | Pharmaceutical Biology | journal | 0.425 Q4 | 88 | 186 | 593 | 6935 | 877 | 588 | 1.64 | 37.28 | |
| 133 | Journal of Stem Cells | journal | 0.426 Q4 | 21 | 21 | 57 | 1745 | 71 | 56 | 0.97 | 83.10 | |
| 132 | Molecular Medicine Reports | journal | 0.428 Q3 | 86 | 533 | 529 | 15143 | 658 | 529 | 1.41 | 28.41 | |
| 131 | International Journal of Peptide Research and Therapeutics | journal | 0.429 Q3 | 45 | 41 | 110 | 1651 | 148 | 109 | 1.37 | 40.27 | |
| 130 | SAR and QSAR in Environmental Research | journal | 0.444 Q3 | 54 | 40 | 122 | 2004 | 234 | 121 | 1.77 | 50.10 | |
| 129 | Advances in Pharmacological Sciences | journal | 0.455 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 128 | MCB Molecular and Cellular Biomechanics | journal | 0.460 Q3 | 31 | 16 | 52 | 458 | 62 | 52 | 0.89 | 28.63 | |
| 127 | Journal of Asian Natural Products Research | journal | 0.461 Q3 | 51 | 175 | 491 | 2815 | 576 | 490 | 1.10 | 16.09 | |
| 126 | Journal of Trace Elements in Medicine and Biology | journal | 0.472 Q3 | 92 | 61 | 140 | 2286 | 355 | 138 | 2.27 | 37.48 | |
| 125 | Biotechnology and Applied Biochemistry | journal | 0.479 Q3 | 81 | 61 | 205 | 2566 | 385 | 203 | 1.62 | 42.07 | |
| 124 | Current Computer-Aided Drug Design | journal | 0.510 Q3 | 32 | 29 | 76 | 1626 | 134 | 70 | 1.80 | 56.07 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data